title: Negative phase II study with carboplatin and 5-fluorouracil in advanced breast cancer.
authors.forename: I
authors.initials: I
authors.lastname: Palacio
authors.forename: J M
authors.initials: JM
authors.lastname: Buesa
authors.forename: L
authors.initials: L
authors.lastname: De Sande
authors.forename: J F
authors.initials: JF
authors.lastname: Cueva
authors.forename: E
authors.initials: E
authors.lastname: Esteban
authors.forename: E
authors.initials: E
authors.lastname: Estrada
authors.forename: J M
authors.initials: JM
authors.lastname: Gracia
authors.forename: A J
authors.initials: AJ
authors.lastname: Lacave
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016190:Carboplatin / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis
chemical_list: D016190:Carboplatin; D005472:Fluorouracil